The tweet was deleted by the author.
But we saved everything 🙂.
NeuroPace Inc is calling on individuals with uncontrolled seizures to participate in a brief online quiz to determine if the RNS System could be a suitable treatment option for them.
The company, focused on advanced therapies for epilepsy, provided additional resources about the safety of the RNS System to support those exploring new solutions for seizure management. Details are being clarified.
NeuroPace previously reported that its RNS System helped patient Brian reduce seizure frequency following a brain injury. The company shared details of Brian’s experience in a prior disclosure. The RNS System remains a core offering as NeuroPace targets individuals with treatment-resistant epilepsy.